Assessment of Anti-RANKL Antibody in Post-menopausal Women
Clinical trial NCT03242512 · UNKNOWN
Trial details
- NCT number
- NCT03242512
- Sponsor
- Jiangsu T-Mab Biopharma Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-07
- Primary completion
- 2018-12-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.